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SUMMARY 
The Leksell Gamma Knife Icon is a stereotactic radiosurgery system that is used 
to non-invasively treat brain lesions. It incorporates 192 fixed cobalt-60 sources, which 
ensures the highest degree of accuracy during treatment due to the minimization of 
potential error from stationary sources. The gamma knife’s precision and special 
modifications for conformity to the human brain ensure faster treatments and fractionated 
options, delivered in a few hours on a single day, as opposed to treatment on consecutive 
days. 
A titanium-alloy frame affixed to the skull of a patient before each treatment has 
defined the stereotactic coordinate system of previous gamma knife models, as well as 
provided complete patient immobilization during treatment. However, the newest gamma 
knife model from Elekta, the Icon, introduced a frameless treatment option that utilizes 
an on-board cone-beam computed tomography (CBCT) imager for patient positioning 
and a motion tracking system to monitor patient movement during treatment. When using 
this option, the stereotactic coordinate system is defined by the CT image taken before 
treatment, and a thermoplastic mask is used for moderate patient immobilization, as 
opposed to the titanium-alloy frame. Since the opportunities for positioning misalignment 
and out-of-tolerance patient movement is now introduced to the treatment, thorough 
research and end-to-end testing was conducted to make sure that correction calculations 
and monitoring methods are being performed to keep these concerns to a minimum and 
provide an accurate and precise radiosurgery procedure. 
 xii 
This project was conducted to consider extreme patient movement during 
radiosurgery procedures and provide additional end-to-end testing on the Leksell Gamma 
Knife system at Emory Saint Joseph’s Hospital in Atlanta, Georgia. The performed 
testing verified the integrated imaging system by treating a moving target that required 
position shifts between treatments to mimic patient misalignments, observing the ability 
of the system to accurately correct patient shifts during setup. Additionally, this work 
evaluated the motion tracking system by treating a moving target, which mimicked 
patient chin-like movements during treatment, monitoring the tolerance at which there 





CHAPTER 1. INTRODUCTION AND PURPOSE 
The Leksell Gamma Knife Icon is a stereotactic radiosurgery system that is used 
to non-invasively treat brain conditions. It incorporates 192 fixed Cobalt-60 sources 
separated into eight independently moveable sectors. This design ensures the highest 
degree of accuracy during treatment due to the stationary sources minimizing potential 
error from motion [6]. The system also includes three collimator sizes (4, 8, and 16 mm), 
which allows for different size radiation shots that offer the ability to create complex 
treatment plans for high conformity to the intracranial structure being treated. The 
Gamma Knife (GK) renders a partial-hemisphere equipment geometry that is designed 
specifically for the human brain to ensure faster, more accurate treatments, which now 
includes a frameless option that can be delivered in a few hours on a single day, as 
opposed to treatment on consecutive days as with conventional linear accelerator 
methods. 
Prior to the Icon system, previous GK models utilized a titanium-alloy frame, the 
Leksell Coordinate Frame G, which was affixed to the skull of a patient prior to imaging 
and treatment. This frame defined the stereotactic coordinate system that specified the 
exact position of the treatment area relative to the frame, as well as provided complete 
patient immobilization during treatment. However, the newer Icon system not only offers 
the frame option but also introduces a frameless treatment option that utilizes an on-board 
cone-beam computed tomography (CBCT) imager for patient positioning and the intra-
fraction motion management (IFMM) system to monitor the patient's movements during 
treatment. When using this option, the stereotactic coordinate system is defined by the 
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cone-beam image taken before treatment. A thermoplastic mask is used in combination 
with the IFMM system to account for the potential for increased patient motion when not 
using the frame. Since the opportunities for positioning misalignment and patient 
movement have been introduced to the treatment with these modifications, end-to-end 
testing was conducted to ensure that correction calculations for positioning and motion 
monitoring methods were being performed to sub-millimeter accuracy. Although end-to-
ending has been conducted acknowledging a motion tolerance of 1.5 mm motion during 
treatment [6], there has yet to be a detailed level of testing that incorporates a moving 
target to imitate common patient movements during treatment. These tests were not only 
conducted to ensure the same high precision and outstanding clinical results as the 




CHAPTER 2. BACKGROUND 
In 1967, Dr. Lars Leksell of the Karolinska Institute in Stockholm, Sweden 
ordered the first gamma knife for construction. Although beginning as a prototype unit 
designed for functional neurological surgery, modern Gamma Knife radiosurgery has 
been used to treat over 300,000 patients and averages over 35,000 new treatment cases 
per year [13]. This method uses beams of highly focused gamma radiation from fixed 
Cobalt-60 sources that converge at a specified focal point to treat brain tumors, brain 
metastases, vascular malformations, trigeminal neuralgia, and other functional indications 
including Parkinson’s disease. 
The physics behind the GK system has remained unchanged with the use of the 
Cobalt sources. Cobalt-60 decays to stable Nickel-60 with the emission of one electron 
via beta decay and two gammas with energies of 1.17 and 1.33 MeV, which are used 
towards the clinical effectiveness of this device. The modern units of the Gamma Knife, 
the Perfexion and the Icon, incorporate an array of 192 sources with an inclusive 
collimation system that directs the individual beams of radiation to a superimposed focal 
point. At this point, a much higher dose rate is incurred, which is then used to target very 
specific areas of tissue without significant damage to surrounding normal areas in the 
brain.  
As the goal with every stereotactic radiosurgery method, the Gamma Knife aims 
to deliver extremely precise high-dose radiation therapy in fewer treatments than 
conventional therapy. This provides the preservation of healthy brain tissue, as well as 
appeal to patients due to shorter overall treatment times. For most GK technology, a 
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restricted lesion size of 35 mm diameter or less is conventional, above which, 
effectiveness begins to decrease due to limitations on the utilization of radiation during 
delivery [13]. Traditionally, linear accelerators have been used to accurately treat every 
part of the body; however, the GK has long made clinical advancements in the treatment 
of the brain. So far, long-term results from this treatment have been documented as 
comparable to other, more commonly used methods of radiosurgery, such as stereotactic 
radiosurgery (SRS) delivered with linear accelerators. Additionally, when compared to 
conventional radiotherapy, the Gamma Knife delivers up to three times lower dose to 
normal brain tissue and up to one hundred times lower dose to the entire body [5]. 
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CHAPTER 3. METHODS AND DESIGN 
3.1 Overview 
The testing that will be discussed in this thesis was done to verify the integrated 
imaging system by treating a shifted target to mimic patient misalignments, observing the 
system’s ability to accurately correct patient shift during setup. Additionally, this work 
independently evaluated the motion tracking system by treating a moving target, 
mimicking patient movements underneath a mask during treatment, which observed the 
tolerance at which there was a clinical detriment to the quality of a simple treatment plan 
due to patient motion. 
In the preliminary considerations for this work, it was understood that end-to-end 
testing for the Leksell Gamma Knife Icon system had been previously documented [6]. 
However, the results and conclusions from previous testing had not thoroughly 
considered the effects of patient movement on radiation delivery to the treatment target. 
With the modifications to the new GK system, which provides a frameless option for the 
treatment, there was an introduction of potential error due to allowed patient movement. 
As per a clinical study conducted at the Princess Margaret Cancer Centre in Canada [2], 
the tracking system upgrade in the Icon system provided an adequate way to track motion 
and deliver treatment to a seemingly stationary target. It was determined by the physicists 
at Emory Saint Joseph’s that it would be beneficial to conduct testing of the system’s 
ability to deliver radiation to a moving target instead, to ensure continued treatment 
accuracy as per the reputation of the stereotactic radiosurgery method. To carry out this 
testing, a phantom that could be used for stereotactic measurements was needed, as well 
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as a moveable platform device which could be rigidly attached to the chosen phantom 
and GK treatment couch, all of which are described in the sections that follow.  
 
3.2 Leksell Gamma Knife Icon System 
The Gamma Knife Icon system is separated into many parts, which are physically 
established into a control room and a treatment room. The control area includes the 
operator console and the Leksell GammaPlan treatment planning software, and the 
treatment room houses the Icon unit, which includes the patient positioning system, 
CBCT gantry, and the IFMM system. Since this work focuses on the verification and 
evaluation of the CBCT and IFMM respectively, the following sections will give concise 
details on each system.  
3.2.1 Cone Beam Computed Tomography 
The C-arm is attached to the most superior location on the gantry of the Icon unit. 
It is generally used for two types of scans, which include the stand alone-scan that defines 
the stereotactic coordinate system for the frameless treatment option and the treatment 
scan, used to verify the patient’s position at the time of treatment. The C-arm is attached 
to the tilt arm, as seen to the left of the unit in Figure 1, which makes it possible to move 
from the parked position to the position that conducts the CBCT scan. It is a rotating unit 
that travels from this scan position through a 180 degree half-scanning path around the 
patient to capture the image and houses an attached X-ray tube and image detector for 




Figure 1 - Front view of the Leksell Gamma Knife Icon system with C-arm 
attachment upright in the parked position [5] 
For each test conducted in this work, the C-arm was used to ensure that any 
offsets of the target location, mimicking a patient’s daily difference in setup position, was 
properly accounted for in the treatment planning system and the resulting shifts to the 
patient’s position align the shots of radiation to the same anatomical position as the 
location in the stereotactic setup and established plan. Since end-to-end testing will be 
conducted using different levels of motion, the C-arm was used to both define the 
stereotactic coordinate system for each level and position the Lucy phantom for treatment 
each time the level of allowed motion is altered. 
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3.2.2 Infrared Motion Management (IFMM) System 
As previously mentioned, the difference between the Icon system and its 
predecessors is its ability to provide a frameless, noninvasive gamma knife option. This 
option introduces potential error to the stereotactic method by gifting the patient with the 
ability to move during treatment underneath the thermoplastic mask that is used in lieu of 
a titanium alloy frame. Since the immobilization capability of the frame remains 
unparalleled, preliminary evaluations of the thermoplastic mask immobilization system 
performed by Winnie Li et al. [11] demonstrated and confirmed the need for both on-
board CBCT and infrared (IR) tracking to achieve intra-fraction motion management of 
the target during treatment. Thus, the infrared motion management system, also referred 
to as the high definition motion management (HDMM) system, is used to monitor patient 
movements during setup and throughout the treatment as the second component to the 
modified GK system to permit the use of the frameless treatment option.  
The IFMM system, as shown in Figure 2, consists of an infrared stereoscopic 
camera, a reflective patient marker, and the reference markers in the mask adapter, which 
connects to the patient’s mask and attaches to at the GK unit. The silver, circular 
reference marker is applied to the nose of the patient during setup on treatment day, as 
shown in Figure 3. The infrared camera is mounted onto an extension on the couch and 
tracks the patient at a frequency of 20 Hz with an accuracy of 0.1mm using the patient 
and reference markers [4].  
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Figure 2 - The infrared motion management (IFMM) system with highlighted 
tracking paths from the infrared camera to the reference markers on the nose of the 
patient and in the mask adapter [4] 
 
Figure 3- Patient in the mask adapter with nose marker and thermoplastic mask [4] 
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When the IFMM is recording patient movement, a graph is shown in the graphic 
user interface (GUI) in both the treatment room and in the control area, where the motion 
is recorded in mm from the starting position and the time duration is in seconds. 
According to Elekta, the default movement tolerance for a patient during treatment is 1.5 
mm, which is considered an active setting because it limits the amount of motion allowed 
during treatment. However, the tolerance can be passively set up to 3.0 mm, in which the 
system does not pause if the patient moves above this limit [6]. Passive treatment is not 
typically used in clinical settings. During treatment under the active tolerance setting, if 
the patient moves out of tolerance for more than two seconds, the treatment is paused, 
and the operator is alerted. As a safety feature, if the patient stays out of tolerance for 
more than 30 seconds, the machine interrupts the treatment moving the patient out the 
unit and blocking the sources from administering radiation. If the patient does not move 
back into tolerance, another treatment CBCT must be taken to account for shifts in the 
setup of the patient before the treatment can be continued. 
It is important to keep in mind that although the motion tolerance level is set with 
respect to the movement at the marker on the nose, the movement of the intracranial 
tumor or other target areas in the brain is the real concern. For this work, the IFMM was 
evaluated for different levels of possible patient motion, ranging from around 0.5 mm 
motion at the nose of the phantom to the extreme case of 5 mm. As mentioned, the 
purpose behind this range is to observe the clinical detriment at which the system and 
corresponding treatment plan begins to fail for accuracy. The platform has both 
horizontal and vertical motion capabilities and will therefore be used to evaluate the 
IFMM for patient motion in the corresponding planes.   
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3.3 Patient Workflow for Frameless Treatment 
Since this work was done to conduct end-to-end testing of the Leksell Gamma 
Knife Icon system, the procedure was written to imitate normal patient workflow. 
Therefore, for comparison, it is beneficial to provide the treatment workflow for a patient 
being treated on the GK with thermoplastic mask fixation and stereotactic references 
defined by the on-board cone-beam CT imager as given in [6]. 
On the first day of the patient’s treatment process, a non-stereotactic simulation 
image is taken using a magnetic resonance (MR) imager or CT to provide anatomical 
information for treatment planning. MR is the preferred method due to its popularity with 
the soft tissue imaging of the brain; however, if the patient is dependent on special 
devices, such as pacemakers, CT will be used due to its lack of magnetism. During this 
simulation, both the thermoplastic mask and a custom pillow needed for setup are fit to 
each patient for treatment immobilization and reproducibility. The patient is then taken to 
the treatment room, where the pillow and cushion is molded onto the mask adapter and a 
stand-alone CBCT on the Icon system is obtained to get the stereotactic reference 
coordinates for the treatment planning. The simulation image is then imported and co-
registered to the reference CBCT image using the Leksell GammaPlan for treatment 
planning, review, and approval. 
On the following treatment day, the patient is setup on the treatment couch in 
approximately the same location as the simulation day using the fixation mask and 
molded pillow. When the patient is in position and the treatment is loaded, the IFMM is 
activated to begin tracking patient motion. A treatment CBCT is taken to correct for 
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shifts that cause the patient target anatomy to deviate from the location coordinates of the 
target during the reference setup, from which the treatment plan was created. Once all 
parameters are corrected and approved, the treatment is administered as pre-planned by 
the administering physicist. Each time the patient moves and stays out of tolerance and 
for each treatment fraction, the setup, imaging, and treatment delivery workflow is 
repeated.    
3.4 Lucy 3D QA Phantom 
As mentioned, a phantom that could be used for stereotactic measurements 
needed to be either chosen or manufactured for this project. The Lucy Three-Dimensional 
(3D) Quality Assurance (QA) Phantom, or Lucy, was designed by Standard Imaging, Inc. 
for quality assurance testing of entire stereotactic radiosurgery procedures and was 
chosen for this project for its availability and feasibility of our predetermined testing 
needs. The phantom is shown in Figure 4 mounted to the precision leveling and rotational 
alignment base, which was not used in this work. Lucy is compatible with angiographic, 
MR, and CT imaging modalities making it a great tool for stereotactic system end-to-end 
testing and process verification. The spherical, radiopaque phantom is manufactured out 
of Lucite plastic, from which the name is coined, and has a diameter of 140 mm. It is 
separated into upper and lower hemispheres and is held together by embedded plastic 
screws (Figure 5), with middle cavities included for holding accessories determined by 
the test at-hand. These accessories include but are not limited to ion chamber inserts, film 
cassettes, marker cylinders, volume and grid inserts for CT scans, and volume inserts and 
signal generators for magnetic resonance (MR) scans.  
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Figure 4 Lucy 3D QA phantom mounted onto the precision leveling and rotational 
alignment base [17] 
 
Figure 5 Lucy 3D QA phantom design with spherical dimensions in mm [17] 
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3.5 Phantom-Platform Device 
3.5.1 Platform Design 
The platform device was designed specifically for this work and was 
manufactured by Matthew Carroll of the Georgia Tech machine shop. Figure 6 shows a 
drawing of the device from the overhead view with labeled parts and dimensions in 
inches. It is approximately 23.75 inches long and 8.887 inches wide and was designed to 
rigidly attach to the mask adapter, used during gamma knife treatments to hold the head 
of a patient, while resting the motor and electronics in an enclosure on the treatment 
couch. The rigid attachment incorporates a semi-circular offset neck and plastic screw 
that was designed to attach the Lucy phantom in an orientation mimicking the head of a 
patient during treatment. The offset became a hindrance to the level of allowed motion 
along the vertical axis, which will be discussed later in this section.  
The pivoting frame was made from nylon polyamide plastic, which was chosen as 
not to severely contribute to the attenuation of the gamma rays during the delivery of the 
plan. There is a screw hole on each of the four sides of the pivoting frame, designed to 
determine the direction of allowed motion once the device is powered on. For instance, if 
the top and bottom plastic screws were in place, only the horizontal motion was allowed. 
Conversely, if the side screws were implemented, a vertical motion was allowed, which 
was included to imitate the most common patient movement at the chin of the 






















Figure 6 - Drawing of the phantom platform device (overhead view) with 
dimensions given in inches 
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The back half of the platform, which rested on the treatment couch, is connected 
to the previously described forward design of the device by way of the base plate and 
driving linkage. The drive linkage screw positions and the attached crank on the posterior 
end of the linkage are what determined the allowed range of motion in the vertical and 
horizontal directions. There were a total of four interchangeable metal cranks that varied 
only in the placement of the center offset hole position. These cranks included 0.025, 
0.050, .0.075, and 0.100-inch offsets labeled on the surface of each, as shown in Figure 7. 
The difference in offset position from the center of the crank allowed for different 
levels of phantom motion when the device was powered on. For the vertical direction, 
only the 0.025-inch offset crank was used due to physical limitations of the platform. 
When other cranks were tested while the platform was in the orientation to produce 
vertical motion, they resulted in levels of motion that caused the posterior end of the 
plastic screw that attached Lucy to the pivoting frame to collide with the top of the frame 
due to the offset placement of the connecting hole. This would cause unwanted jumps 
during the motion and consequently in the motion-tracking graph on the GUI, which 
made measurements with cranks larger than 0.025-inch more troublesome. Instead, one 
crank was used, and the length of driving linkage was adjusted to produce different levels 
of motion in the vertical direction. For the horizontal direction, on the other hand, each of 
the offset cranks was used to allow different levels of motion. The motions were then 
fine-tuned for comparability to the vertical direction by adjusting the position of the 
driving linkage. These changes in the levels of motion were imperative for the evaluation 
of the infrared motion management system and its ability to monitor movement during 
treatment. The testing workflow, which includes the levels of achieved motion from the 
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Figure 7 - Offset cranks that determined the levels of motion for the device 
 
Lastly, the back portion of the platform contained the electronics enclosure, which 
was 3D printed with blue styrene plastic. The enclosure housed a 12V DC motor, a 
DMC60 digital motor speed controller, an Arduino Leonardo microcontroller to read the 
position of the knobs that controlled the speed, and a 12V power supply. The turn switch 
that controlled the speed of the device was located on top of the enclosure, and the device 
had two power switches, one next to the turn switch and one on the back end of the 
enclosure underneath the power cord.    
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3.5.2 Platform Motion Geometry  
Although designed to imitate normal patient movement, the levels of motion 
produced by the platform in this work were of extreme consideration. This was due to the 
fixed location of the film inside of the Lucy phantom film insert in relation to the nose 
that was placed on surface of the phantom. The film was located approximately 100 mm 
from the center of the pivoting frame, whereas, the nose was placed closer, at 
approximately 60 mm from the frame. Since the C1 vertebra in the neck is the most 
natural pivoting point for a human head, it is possible for this geometry to occur when 
considering a real patient. This would be a case in which the vertebra is closest to the 
nose and furthest away from the tumor. However, it should be noted when considering 
the data acquired from this work that this was a very specific geometric case, in which 
the “tumor” location was much further from the pivoting point than the marker location at 
the nose in the horizontal plane. This would impact the movement at the film in relation 
to the movement at the marker on the nose by magnifying the target motion at the center 
of the phantom in all planes considered for this work.  
Figure 8 is an illustration of the effects from the setup geometry on the level of 
motion allowed at both the film in the middle of the phantom and the nose marker at the 
surface of the phantom. This will be further considered for the effects on the acquired 


















Figure 8 - Effects of the platform-phantom geometry on the level of motion allowed 
at the centered film and at the nose of the phantom. Diagrams a. and b. are side 
views of the levels of motion allowed in the vertical plane at the film and nose, 
respectively, due to their locations along the pivoting axis (in green). Diagrams c. 




3.6 GAFChromic EBT3 Dosimetry Film 
For this project, the treatment plan was delivered to the Lucy 3D QA Phantom 
containing GAFChromic EBT3 film from lot number 05011701. GAFChromic EBT3 
dosimetry film was developed to address the needs of dosimetrists and medical physicists 
in clinical environments by measuring absorbed doses of ionizing radiation, particularly 
high-energy photons. It is suitable for testing applications such as those conducted using 
image-modulated radiation therapy (IMRT), volumetric arc therapy (VMAT), and 
brachytherapy, exhibiting its highest performance in the dose range from 0.2 to 10 Gy. 
The structure of the GAFChromic EBT3 film is comprised of two outer layers of matte-
polyester substrate each with 125um thickness and a 28um-thick inner active layer 
containing marker dye and stabilizers, which yields a nearly energy-independent response 
of the film. The active layer is so called because when it is exposed to ionizing radiation, 
it reacts when the absorption maxima is at 633 nm to form a blue polymer, which shows 
through the clear outer layers of the film. Figure 9 shows a drawing of the film structure 
as described.  
 
Figure 9 Structure of GAFChromic EBT3 Dosimetry Film [9] 
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Like its predecessors, EBT3 film is self-developing through a polymerization 
process, which is an induced chemical reaction of the monomers in the active layer of the 
film. To fully utilize this feature, the film must be exposed and digitally scanned 24 hours 
after irradiation, which is the peak of its self-development. The film has minimal energy 
dependence from 100 keV into the MV range, making it safe to handle in interior room 
light for short periods of time without altering the darkening of the film. However, as per 
[9], it is advised for the film to be stored in the dark away from radiation sources at 
temperatures below 25 degrees Celsius as a precaution.    
 
3.7 Leksell GammaPlan 
The Leksell GammaPlan is a treatment planning system designed specifically for 
Leksell Gamma Knife stereotactic radiosurgery models. Planning is based on processing 
projectional and tomographic images using a computer workstation running the software. 
GammaPlan can handle acquired images from modalities such as computed tomography, 
magnetic resonance imaging, positron emission tomography (PET) scanners, and 
angiograms (AI), all of which allow direct comparison of vascular and tissue structures. 
The workflow of creating a plan in the GammaPlan system includes defining the targets 
and treatment dose, configuring the treatment collimators, and determining the shots of 
radiation to be delivered by the Icon system [7]. 
Due to minimal moving parts in the Leksell Gamma Knife models, GammaPlan is 
known and revered for its simplicity. Since the models have inherent accuracy, safety, 
and reproducibility features, the main area that GammaPlan is designed to perfect is the 
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precision science for delivering very high intensity shots of radiation to the correct 
intracranial locations. The software does not have any remote control during the 
radiosurgery procedures; therefore, a plan including the correct structure definition and 
shot placement must be established, reviewed, and approved for final use before the 
treatment begins. 
The sub-millimeter accuracy of the GK models is obtained with the incorporation 
of the stereotactic coordinate and reference system that is shared with the Leksell 
GammaPlan for each patient during treatment planning. Two ways to define the 
stereotactic reference coordinates are by using the indicator box for the Leksell Frame G 
during image acquisition and with the use of the on-board CBCT imager only available 
on the Leksell Gamma Knife Icon System. This work is focused on the frameless 
treatment option for the Icon, and therefore, only the reference system as defined by the 
CBCT will be discussed. Since the CBCT is an integrated part of the newer Icon system, 
the entire system is calibrated for the same spatial reference. The CBCT spatial reference 
was made to match that of the machine, so no other external reference, such as the 
indicator box with the frame, is needed.  
 
3.8 End-to-End Testing Procedure 
3.8.1 Platform Setup 
First, the decision was made that the “nose” of the Lucy phantom would be a 
hollow, plastic ion chamber holder that was filled with tissue equivalent aquaplast 
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thermoplastic pellets to reduce air gaps and beam scatter. It was then wrapped with tape 
to eliminate reflective interference to the IFMM from the plastic surface. The surface of 
the phantom was also taped and wrapped in Bandnet tubular elastic dressing to further 
minimize reflective surfaces. The nose was attached to the surface of the phantom using 
double-sided adhesive tape, and an infrared reflective sticker was placed on its surface to 
be seen by the IFMM. The complete setup from this work with the QA phantom is shown 
in Figure 10. 
 
Figure 10 The Lucy phantom attached to the platform device in the mask adapter, 
with nose marker and non-reflective surface coverings 
The Lucy phantom housing the film cassette insert with fiducial markers, was 
connected to the platform device and a simulation CT image was obtained using a Philips 
CT Big Bore scanner. This scanner is used daily at Saint Joseph’s and provides a 60-cm 
true scanning field of view for a multi-sized patient population, as well as spatial 
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positioning accuracy of less than 2 mm, as required in the American Association of 
Physicists in Medicine (AAPM) Task Group 66 (TG-66) protocol [15]. The simulation 
image was then reconstructed and sent to the Leksell GammaPlan for planning. MRI was 
not used for this work, as it would be in normal patient workflow, due to the lack of 
image contrast that would result from imaging the radiopaque phantom. The fiducial 
markers in the phantom would not be visible in MR, rendering the image of no use for 
this project. Additionally, regarding the simulation in normal workflow, a thermoplastic 
mask and pillow were not needed. 
For this work, only the film cassette insert was used to hold film in the center of 
the Lucy phantom during dose delivery to emulate a centered intracranial tumor. 
GAFChromic EBT3 film was cut into approximately 5x5 cm squares that fit inside of the 
film cassette insert of the Lucy phantom, as shown in Figure 11, to be irradiated during 
these tests. The insert had a pinprick in each of the corners of the square plug-in, with 
two pricks in what was considered the upper right corner. Since GAFChromic film 
orientation is extremely important for absorbed dose measurements [8], the corner of the 
plug-in with two pricks was beneficial in keeping both the alignment and orientation 
accurate. After the film squares were irradiated, they were labeled with the film number, 
which sorted them by the level of motion used for each delivery. Section 3.9 offers 




Figure 11 - Overhead view of the film cassette insert inside of the Lucy phantom 
The phantom-platform device was taken to the treatment room and attached to the 
treatment couch using the mask adapter, which was then secured with blue clinical tape. 
To hold the platform at a firm flattened position, solid water blocks were used in the 
space between the mattress of the treatment couch and the posterior end of the device. 
Figure 12 is an overhead view of the setup that was maintained throughout the duration 
of this work. In this position with the motion powered off, a stand-alone CBCT was 
obtained at the beginning of the workflow for each level of motion, which defined the 
stereotactic coordinate system. 
 26 
 
Figure 12 - Overhead view of the phantom-platform device holding Lucy in an 
orientation mimicking the head of a patient during treatment 
3.8.2 Simplification of the Treatment Plan 
With popular treatment equipment, such as linear accelerators, operators have the 
option to input a certain number of monitor units, calibrated to the amount of dose 
delivered to the target, which can then be quickly delivered once all interlocks on the 
device are clear. However, in gamma knife systems, there is a specific workflow that 
must be followed before each irradiation. This begins with the planning of a treatment 
designating parameters such as the coordinates for the location of the target, the amount 
of radiation to be delivered, the radiation prescription isodose line to the target, and 
radiation collimation. In the control area, treatment planning using Leksell GammaPlan 
began as it would in normal patient workflow, with a target shot being placed at the 
center of the film holder using the fiducials in the simulation CT. Then the simulation CT 
was co-registered to the reference CBCT to locate the target area coordinates for which 
the radiation shot would be placed. A simplification for this work was that treatment 
plans of only one 16 mm symmetric radiation shot was delivered. This could be 
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considered a worst-case scenario for actual patient treatment because it results in a shaper 
gradient, where there would be more dramatic dose differences at the edges than in a 
more complex plan with shallow dose fall-off. Nevertheless, single shots are sometimes 
clinically used for mask patients, and therefore, a simple treatment plan of just one 16 
mm target shot was determined to sufficiently evaluate the capabilities of the integrated 
imaging and motion management systems for the Leksell Gamma Knife Icon.  
3.8.3 CBCT and IFMM Evaluation 
The shot was planned to deliver 5 Gray (Gy) to the 100% line of the target, which 
is at the center of the target area, determined to be 100.3, 138.4, and 79.5 in Cartesian 
coordinates. This was numerically based off the reference CBCT coordinates but visually 
based off the CT simulation. The co-registration of the treatment CBCT and the reference 
CBCT began the evaluation of the integrated CBCT imager, which would be monitored 
for accurate shot placement through the entirety of the project for each change in motion 
level. Due to a limitation of the design having no home or base position, the stereotactic 
coordinates were different at each level of motion to account for the shifts acquired from 
removing the phantom to insert new film between each test. The goal was that each 
resulting shift determined by the cone-beam taken at each level, would place the shot in 
the same anatomical position as the initial shot position. 
As a baseline for later treatment comparison in the data analysis, the first plan was 
delivered to the Lucy phantom in a stationary position, meaning there was no motion 
from the platform. The plan was conducted in 1.9 minutes, or 114 seconds, delivering 5 
Gy to the center of the target film. Next, the task was to deliver the same plan to a 
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moving target, in which the Lucy phantom would consistently oscillate along one axis 
(either vertical or horizontal) at varying levels of motion. The levels of motion were 
determined by the manipulation of the screws connected to the driving linkage and the 
interchangeable cranks, as described in Section 3.5. Once the film was changed and the 
platform was put back together after each adjustment, the motion was turned on and 
observed for approximately two minutes on the GUI in the treatment room to allow the 
motion to become as consistent as possible. After a consistent range was determined, the 
platform was stopped at a documented midpoint in the range of motion, in which the 
position was held for acquisition of the CBCT. The C-arm was manually driven to the 
scanning position before leaving the treatment room in preparation for the treatment 
CBCT (CBCTt) that would make the necessary shifts to place the shot in same position in 
the phantom as in the original plan. The CBCTt acted as a zeroing factor for that specific 
position, meaning that once the motion began again, there would not be any oscillations 
below the current position, shown as zero on the GUI. Instead, the graph would show a 
continuous oscillation above the zeroed position that would only track how far away the 
infrared marker on the nose would get from the chosen (baseline) position. This yielded 
the experimental value of the level of motion at the nose of the phantom that will be 
compared to the measured level of motion in the center of the film. This is important 
since in normal patient treatment, the marker and monitoring of the movement nose is 
simply a surrogate for the movement of the tumor, which is the real concern.  
Once satisfied with the obtained level of motion, the plan was delivered to the 
phantom while the platform continued oscillating along the chosen axis. After the plan 
was delivered, a CBCT was taken at the maximum point in the range of motion (CBCTm) 
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to measure the total displacement from the baseline of the range. The CBCTm and the 
CBCTt were both used to determine the measured amount of motion at the center of the 
film by taking the difference in Cartesian coordinates of the fiducial markers shown on 
the images in reference to the Leksell coordinate system. In the data analysis, this value 
for the motion at the center of the film, which is the primary concern in clinical settings, 
was compared to the movement at the nose. 
After each irradiation, the Lucy phantom was taken apart, the irradiated film was 
marked, and a new piece of EBT3 film was inserted in the proper orientation as shown in 
Figure 11. The importance of film orientation for film calibration and analysis will be 
discussed in the following section. After the new film was inserted and Lucy was 
reinstated on the platform, the above steps for the moving platform treatment delivery 
were carefully repeated for each obtainable level of motion. Since two CBCT images 
were taken per film, the dose from these images was also considered in the data analysis 
of each irradiated film. 
 
3.9 Absolute Film Dose Calibration 
3.9.1 Optical Density 
When discussing dosimetric film, the most important parameter is radiographic 
density, or optical density (OD), which is a measure of the degree of film darkening after 
exposure. It is defined as the logarithm of the ratio of the incident intensity (𝐼0) on the 
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film to the intensity of transmitted light (𝐼𝑡) through the film. This is written 
mathematically as  




Generally, the absorbed dose to the film is proportional to the change in optical 
density, where the change in optical density is defined as the exposed optical density 
minus the unexposed optical density. To consider changes to the film due to background 
radiation, a piece of film used as a control is monitored, and the change in the control OD 
is subtracted from the change in OD from the exposed film, shown as  
△ 𝑂𝐷𝑛𝑒𝑡 = 𝑂𝐷𝑒𝑥𝑝𝑜𝑠𝑒𝑑 − 𝑂𝐷𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑 − (𝑂𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑎𝑓𝑡𝑒𝑟 − 𝑂𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑏𝑒𝑓𝑜𝑟𝑒)  (2) 
where 𝑂𝐷𝑒𝑥𝑝𝑜𝑠𝑒𝑑 and 𝑂𝐷𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑 are the optical densities of the exposed and unexposed 
film, respectively, and 𝑂𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑎𝑓𝑡𝑒𝑟 and 𝑂𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑏𝑒𝑓𝑜𝑟𝑒 are the optical densities of the 
control film before and after exposure to account for background radiation. 
Therefore, by substituting equation (1) into equation (2), an expression for the net 
optical density in terms of intensity is obtained as 
△ 𝑂𝐷𝑛𝑒𝑡 = 𝑙𝑜𝑔 (
𝐼𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑
𝐼𝑒𝑥𝑝𝑜𝑠𝑒𝑑




where 𝐼𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑 and 𝐼𝑒𝑥𝑝𝑜𝑠𝑒𝑑 are the intensities of the test film before and after its 
exposure, respectively, and 𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑏𝑒𝑓𝑜𝑟𝑒 and 𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙,𝑎𝑓𝑡𝑒𝑟 are the intensities of the 
control film before and after the time of exposure, respectively [10]. 
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3.9.2 Film Calibration 
Ideally, a product of any type would produce test results that matched with no 
error to every point of the sampled values within the calibrated range. However, this is 
not true for anything, especially not dosimetric film used for clinical measurements, 
where the environment is constantly changing due to several factors. This includes 
factors such as the usage of a piece of equipment, variations in equipment calibration, and 
time differences in regard to the amount of film darkening allowed during self-
development. For analyzing film used for dosimetric measurements, absolute dose 
calibration is important because film darkening is not a linear occurrence; rather it is seen 
to be an exponential or piecewise function.  
With all versions of GAFChromic film, it should be noted that consistency in the 
orientation of the film when it is cut and consequently when it is scanned for digital 
calibration is imperative. In the preceding film models, EBT1 and EBT2, both orientation 
and film side placement were important due to the different thicknesses of the outer 
polymers, which protect the active layer of the film. However, the EBT3 provides equal 
outer thicknesses making only consistency in orientation important due to symmetry. 
Once film calibration is conducted, inconsistent orientation of the film has been observed 
to cause up to a ten percent discrepancy in the dose and dose distribution, which leads to 
faulty data analysis. Film handling should be done with extreme caution, preferably by 
the edges of the film using gloves. Fingerprints or debris on the film surface may be 
problematic during scanning and digital analysis. For this work, the EBT3 film was cut 
with a guillotine cutter in approximately 5x5cm squares and marked in the upper right 
corner to keep the vertical orientation consistent in relation to the original sheet. The 
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vertical orientation was held constant for both the calibration exposures and for test 
measurements as per the protocol [8]. 
After the film was cut for calibration, treatment plans were made using Leksell 
GammaPlan to deliver one shot of radiation to the center of a piece of film in consecutive 
doses of 1, 2, 3, 4, 4.5, 5, 5.5, 6, 7, and 8 Gy. The film calibration sphere, which is a GK 
dosimetry tool, was attached to the head of the treatment couch and used to hold the films 
in the head of the machine during irradiation. After each exposure, the film squares were 
labeled with the administered dose and a new square was inserted for the next delivery. A 
piece of the film was also set aside as a control with no dose being delivered. Recall 
Equation 2 in the previous section. In normal calibration calculations, the dose from the 
control piece at the scanning time 24 hours later would be subtracted from the other 
irradiated squares to account for possible background radiation dose to the film. 
However, the Radiation Imaging Technology (RIT113) dosimetry software, which was 
used for this calibration as well as the dose measurements for the project, was not 
programmed to consider background radiation dose significant due to improvements in 
the uniformity of the film. Therefore, the 0 Gy film was only used as a starting point for 
the data collected to generate the calibration curve, as opposed to a correction factor for 
the change in optical density of the film.  
When discussing film calibration, it is additionally important to consider how the 
Leksell GammaPlan treatment planning system calibrates dose to be administered to the 
films. Due to the complicated partial-hemisphere arrangement of the Cobalt-60 sources 
and the rigid geometry of the Gamma Knife, there is currently no officially accepted 
protocol for the dosimetry of the device [14].  However, a modified version of the 
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American Association of Physicists in Medicine (AAPM) Task Group 21 (TG-
21) protocol using air kerma based dosimetry, a solid water phantom, and an air 
ionization chamber is widely used [12]. AAPM Task Group 51 (TG-51), an updated 
version of TG-21, calls for the utilization of farmer chambers in water phantoms for 
clinical reference dosimetry measurements [1]. It requires absorbed dose to water 
calibration factors, making the measurements, concept, and implementation of this 
method easier than earlier protocols. The absorbed dose-to-water factors are needed 
because the thin electrode, or collector, in a farmer chamber is surrounded by graphite, 
which acts as an insulator to generate the electric field needed to measure the dose and is 
also water and tissue equivalent [3]. Although the Leksell GammaPlan is calibrated using 
these absorbed dose-to-water factors, the dosimetry Task Groups, were written for 
teletherapy beams only, in which the radiation originates at a single source that is 
broadened to form a uniform field. This is a very different consideration from the 192 
radiation sources of GK, which focus at a single point in the head of the machine. 
Conclusive testing of TG-21 with corrected air kerma dosimetry [14] has been conducted 
and deemed acceptable for the calibration of the GK until a formally accepted method is 
implemented. Therefore, the dose that is calibrated with absorbed dose factors by the 
Leksell GammaPlan to be delivered by the Icon, which itself is widely calibrated with air 
kerma dosimetry, yields a delivered dose that is slightly lower than the expected value. 
The tolerance for this discrepancy has been evaluated, accepted, and established until 
future protocol acceptance is obtained.  
  
 34 
3.9.3 Absolute Dose Calibration Curve 
As mentioned, the GAFChromic EBT3 film must be digitally scanned 24 hours 
after irradiation to give the film time to self-develop as well as to prevent any extra 
darkening from exposure to background radiation, such as light. The Epson 11000XL 
scanner, which is the recommended scanner model for GAFChromic film [9], was used 
to digitize all film in this project. The scanner utilizes 48-bit color, which activates three-
color channels (Red-Green-Blue) with 16-bits per channel, and 400 dots per inch (dpi) 
resolution, which corresponds to 0.1 mm per pixel. During the film import however, only 
the Red color channel was used for display, corresponding to the greatest change in 
optical density in GAFChromic film. The Epson 11000XL scanner response to exposed 
GAFChromic film is given by  
X(D,n)=a+b(D-c) (4) 
where D is the dose administered and a, b, and c are constants. This behavior of 
GAFChromic film is rationalized by the fact that the film becomes less transparent as the 
delivered dose increases and the response asymptotes at very high doses [8].  
Both the film calibration and analysis were conducted using the classic version 
RIT113 V6.3 of the RIT software. As previously discussed, this software does not take 
into consideration dose from control film that would take into account the change in the 
optical density of the film from background radiation as considered in Equation 2. 
Instead, only the irradiated film from each delivered dose is analyzed with the assumption 
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that each piece of film had no dose before the irradiation and was also unaffected by a 
background dose during the 24-hour self-development before they were scanned.  
To generate the absolute dose calibration curve, the RIT software calculates the 
full-width half maximum (FWHM) of the dose distribution by the optical density of the 
scanned film. Each film square is analyzed separately so that the center of the FWHM is 
chosen to be the point at which the full amount of dose from the delivery was prescribed. 
A pixel value corresponding to the prescribed dose is given to that point and plotted. 
Figure 13 shows the absolute calibration curve generated by this method for the 
GAFChromic EBT3 film used in this work. During data analysis, this calibration was 
applied to each film before analysis was conducted in the software to correct for the 












Figure 13 - The absolute calibration curve for the GAFChromic EBT3 film from lot 




CHAPTER 4. RESULTS AND DISCUSSION  
4.1. Experimental vs. Measured Levels of Motion  
As described in Section 3.2, the infrared camera that tracks the movement of the 
patient during frameless treatment on the GK does so by monitoring the 
displacement of the marker placed on the nose of the patient relative to the 
reference markers in the mask adapter (Figure 2). However, recall that the nose 
movement is solely a surrogate for the motion of the tumor during treatment, which 
is the real concern. Elekta, the manufacturing company of the Leksell Gamma 
Knife, stated in [4] that the movements observed by the HDMM at the nose are 
larger or equal to actual target movements in the skull of a patient. Therefore, 
although the default tolerance of movement at the nose is set to be 1.5 mm, this 
should only correspond to sub-millimeter movements at the tumor. Observations 
from this work dispute the universal proclamation from Elekta that movement at an 
intracranial tumor is less than what is seen at the nose.  
 
Table 1 and Table 2 show the levels of motion and corresponding crank used to 
produce that motion in the vertical and horizontal planes, respectively. Recall that in the 
vertical direction, only the 0.025 mm crank was used and the screws on the driving 
linkage were adjusted to produce motion level variation. As described in Section 3.8.3, 
the experimental value was obtained at the nose of the phantom using the level of motion 
as seen by the IFMM, and the measured values were calculated using vector analysis of 
the displacements yielded from the CBCTs taken at the baseline and maximum point in 
each range of motion.  
Section 3.5.2 gave an account for the geometry of the phantom-platform setup, 
which was a key factor in the differences of allowed movement at both locations during 
these tests. For the geometry used in this work, a trend was noticed that the movement at 
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the film was greater than the movement at the nose, experimentally observed with the 
IFMM system in all films except for Film 4. As previously mentioned, challenges were 
faced in the vertical direction to produce different levels of motion using one crank due to 
the physical limitations of the platform. Considering these limitations, how the phantom 
moved and drifted due to collisions with the pivoting frame and increased amounts of 
motion was a cause of experimental uncertainty. Since the measured motion in the table 
was calculated from the CBCTs taken at the baseline and maximum of the range of 
motion, this value is taken to be the more accurate of the two values. This means that 
Film 3 and Film 4 were inadvertently irradiated for about the same level of motion, 
approximately 2.5 mm. However, the remaining films exhibited the trend for the motion 
at the center target being larger than the motion experimentally seen at the nose. 
Therefore, although smaller motions yielded similar results between the two positions, 
discrepancies began to clearly be observed above the experimental value of 1.5 mm of 
motion. In fact, in the horizontal direction above 3 mm, the difference in motion between 






Table 1 - Experimental (at the nose) and measured (at the center) values of the level 
of motion achieved by the platform in the vertical direction 
Film Crank (mm) Experimental (mm) Measured (mm) 
1 0.025 0.5 0.5 
2 0.025 1.5 1.9 
3 0.025 2.0 2.6 
4 0.025 3.4 2.5 
5 0.025 4.0 4.7 
 
Table 2 - Experimental (at the nose) and measured (at the center) values of the level 
of motion achieved by the platform in the horizontal direction 
Film Crank (mm) Experimental (mm) Measured (mm) 
6 0.025 0.3 0.8 
7 0.050 1.3 2.3 
8 0.075 1.7 2.7 
9 0.100 3.2 5.7 






4.2. Absolute Dose Measurements 
4.2.1 Absolute Dose Curves 
Film measurements were conducted in this work as described in Section 3.8. The 
administered dose was 5 Gy to the center of the film, or the 100% isodose line in the 
target, for different levels of motion produced by the platform device in both the vertical 
and horizontal planes. In between each irradiation, Lucy was taken apart, a new piece of 
EBT3 film was reinserted before the motion was adjusted, and the irradiated film was 
labeled and set aside to be digitized on the following day. 
The first film that was irradiated was done at a stationary, midline position and 
was considered the baseline and reference image during data analysis. Each film that 
followed was irradiated while in constant motion for the documented level as produced 
by the platform. Since the motion was constant during the radiation delivery, it should be 
noted that this was a deviation from normal patient behavior. Clinically, some of the 
major challenges observed during treatment delivery are situations where the patient 
continues to fall asleep during delivery, snore, or have a hard time holding still. 
Something commonly observed is the tendency for their chin to continuously drift 
downward in the thermoplastic mask each time. This would cause frequent interruptions 
of the treatment, in which another CBCT would be needed for the treatment to be 
continued. Even in this case, the chin motion underneath the mask is not a continuous 
oscillation as with the platform. Therefore, for all motion considered in this work, the 
results will be described for the extreme case of constant patient motion during treatment. 
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For each film, a total of two CBCTs were taken, one at the baseline for that 
particular range of motion to begin the treatment and one at the maximum displacement. 
This was done to later measure the motion at the film located in the center of the Lucy 
phantom using vector analysis between the two images. The dose given to the film from 
these CBCT images were taken into consideration by seperately irradiating a piece of 
film with only one cone-beam image. After analysis, it was observed that the CBCT 
contributed no more than 10cGy  to the overall irradiation of the film. Compared to the 
administered 5 Gy, or 500cGy, the contribution of the two CBCTs for each film was 
considered insignificant, and the subtraction was therefore omitted from the data analysis 
for this work.  
After the film calibration was conducted as described in Section 3.9 and the 
irradiated test films were each digitized using the Epson11000XL scanner, data analysis 
began by applying the calibration to each of the films in the RIT113 dosimetry software. 
Once the test films were calibrated and saved, each of the target films that were irradiated 
during constant motion were individually compared to the reference image that was taken 
with no motion. This could be done because the reference film was initially analyzed and 
found to have received 5 Gy at the center of the film, determined by the center of the 
pinpricks. The geometric center of the film was within the 0.5 mm tolerance of the GK. 
This means that for the irradiation of the stationary target, the shifts from the CBCT were 
performed and the dose was delivered properly and within tolerance, which is verification 
that the film could be used as a baseline reference to compare to the films that were 
irradiated with motion. The comparison was done to observe the deviation in absolute 
dose and dose distribution from that administered to a stationary target. For this, the 
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reference image was registered to a specific target image using the pinpriks that were 
made on each film by the film insert cassette in the Lucy phantom, and the data was 
plotted for comparison in the vertical and horizontal profiles of the film. Figures 14-18 
are the absolute dose curves in the vertical (red) and horizontal (green) profiles of the 
film for each vertical motion produced in this work, where the y-axis is the dose given in 
cGy and the x-axis is the position on the film given in cm. Figures 19-23 are the absolute 
dose curves with the same considerations for each horizontal motion. 
It was expected that the film profile (vertical or horizontal) corresponding to the 
allowed direction of motion for each film would have the most amount of deviation from 
the reference curve. For example, as the vertical motion increased, the plot for the target 
image would be expected to have a smaller profile along the vertical profile of the film 
than in the horizontal, and the opposite would be true for the horizontal motion.  
However, since the motion of the platform was not solely a two-dimensional (2D) motion 
but rather a sweeping motion in each direction, this was not observed. The sweeping 
motion acted in the intended direction of motion but also caused additional movement 
both towards and away from the isocenter in each direction. Therefore, instead of the 
predicted motion and film profile plot correspondence, the orthogonal profiles for the 
larger motions in both directions showed the most deviation from the reference image. 
The design of the device and the convergence of the gamma radiation sources in the head 
of the machine interacting with the sweeping phantom motion may have been additional 
contributors to this deviation. Nevertheless, the unpredictable movements of the phantom 
made a detailed explanation for the dose distribution on the film a more complex issue. 
To fully understand the dose distribution, machining improvements for certain parts of 
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the device are needed, such as metal replacements for some of the plastic components 
Additionally, multiple CT images of the device at each level of motion may be beneficial 

















Figure 14 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
1, which had 0.5 mm vertical motion as observed by the IFMM, compared to the 
reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm.  
 
Figure 15 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
2, which had 1.5 mm vertical motion as observed by the IFMM, compared to the 
reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm. 
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Figure 16 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
3, which had 2.0 mm vertical motion as observed by the IFMM, compared to the 
reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm. 
 
Figure 17 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
4, which had 3.4 mm of vertical motion as observed by the IFMM, compared to the 
reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm. 
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Figure 18 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
5, which had 4.0 mm of vertical motion as observed by the IFMM, compared to the 
reference film with no motion. The dose along the y-axis is given in cGy and the 





Figure 19 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
6, which had 0.3 mm of horizontal motion as observed by the IFMM, compared to 
the reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm. 
 
Figure 20 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
7, which had 1.3 mm of horizontal motion as observed by the IFMM, compared to 
the reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm. 
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Figure 21 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
8, which had 1.7 mm of horizontal motion as observed by the IFMM, compared to 
the reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm. 
 
Figure 22 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
9, which had 3.2 mm of horizontal motion as observed by the IFMM, compared to 
the reference film with no motion. The dose along the y-axis is given in cGy and the 
depth (or width) along the x-axis is given in cm.  
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Figure 23 - Absolute dose curves in the vertical (l) and horizontal (r) profiles of Film 
10, which had 5.3 mm of horizontal motion as observed by the IFMM, compared to 
the reference film with no motion. The dose along the y-axis is given in cGy and the 






4.2.2 Dose Coverage for a Moving Target  
As with all methods of radiation therapy, dose coverage for a target volume is an 
important topic and consideration during treatment planning and delivery in Gamma 
Knife procedures. Since GK is a radiosurgical procedure used for intracranial structures, 
which utilizes shots of intense gamma radiation to small targets, accuracy and coverage 
are highly considered in each case to give as much dose as possible to the target while 
keeping the dose to healthy surrounding brain tissue to a minimum. Although Elekta 
gives a 1.5 mm motion tolerance as measured at the nose by the IFMM system [6], it is 
useful to know the effects of motion on tumor coverage for different levels of motion and 
patient geometries.  
For the extreme case of constant patient motion and nose-to-target geometry in 
which the tumor is situated much further from the pivot point than the nose along the 
horizontal plane, the absolute dose curves for vertical and horizontal motion (Figures 14-
23) are considered. For a tumor approximately 1.5 cm in size, a shot of 5Gy to the center 
of the tumor would yield 100% coverage for a stationary target, as seen by the Reference 
image in all figures above. Even for motion observed at the nose as less than 2.0 mm in 
the corresponding film profile for both planes, full coverage would still be achievable.  
However, above this level, specifically above 3 mm as measured at the nose for the 
producible motions in this work, the percentage of tumor coverage begins to drop. A 
more thorough evaluation using 3D analysis would be needed to accurately give the 
decreases in percentage of volumetric coverage for this hypothetical tumor evaluation.  
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Consider the horizontal profiles of Figure 22 and Figure 23 for the same tumor, in 
which the tumor would not receive full coverage due to motion above 3 mm. Instead, 
margins around the tumor would be needed to maintain coverage, which would be a 
function of the size of the tumor and the amount of motion. The location of the tumor in 
relation to the pivot point should also be considered. As mentioned, this data was 
acquired using a specific geometry placing the target location further from the pivoting 
point than the marker at the nose. For closer tumor locations, motion would not be as 
much of a hindrance due to a smaller pivoting axis. Therefore, tumor coverage would 
remain high for large amounts of motion at the nose for closer tumors, whereas for more 
superior tumors, coverage would decline much quicker. 
Additionally, the prescription isodose lines were considered for tumor coverage. 
In this work, the dose was consistently planned to the 100% isodose line at the center of 
the target. This corresponds to the peaks of each absolute dose curve in Figures 14-23, 
where deviations between the reference and target film become larger with increased 
motion added to the system. However, clinical gamma knife treatments are often 
prescribed to the 50% isodose line instead, and for more complex targets, the prescription 
isodose lines may vary even more. Since the dose delivered for this work was one 16 mm 
shot of 5 Gy, a prescription to the 50% isodose line would correspond to two shots of 2.5 
Gy of radiation. Considering the same 1.5 cm tumor as before and the same plots for 
horizontal motion, Figure 22 and Figure 23, this would now mean that even with the 
large horizontal motion, there would be no loss of coverage for a 50% isodose 
prescription. Only the maximum dose changes were considered above; however, when 
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discussing motion at the tumor, the tumor coverage was shown to also depend on the 
prescription isodose lines used for the treatment delivery. 
4.2.3 Plot Statistics  
Both the differences in absolute dose and the penumbra region of the target curves 
when compared to the reference images were considered for the conclusions of this work. 
A few of the data plots had falloff regions at the edges that were caused by software 
intereference during gamma analysis from the permanent marker used to label the films. 
Additionally, for larger motions as observed in Figures 22 and 23, the descrepencies at 
the edges of the plots were due to the amount of time it took for the phantom to move to 
each side of the range of motion during irradiation. This caused the dose to be widely 
distributed over the film and accumulate more in the regions where the most time was 
spent. The plot statistics given in Tables 3 and 4 took these fall-off areas into 
consideration and omitted them as not to hinder the most accurate information from being 
obtained from the corresponding absolute dose curves. The maximum and mean 
differences and the standard deviation values in the tables are given in cGy. For the larger 
motions in each plane, as in Film 5 (vertical) and Films 9 and 10 (horizontal), the 
maximum difference between the reference and target curves are greatest due to 
deviations in dose distribution caused by the increase in the level of motion being a 
detriment to the quality of the treatment plan delivered to the film.    
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Table 3 - Plot statistics corresponding to the absolute dose curves in Figures 14-18 
for target films irradiated with constant vertical motion, compared to the reference 
film with no motion 






1 Vertical 27.08 7.77 5.87 
Horizontal 27.43 8.51 6.74 
2 Vertical 38.46 11.38 6.80 
Horizontal 46.23 8.45 10.63 
3 Vertical 26.65 3.86 5.92 
Horizontal 59.00 3.08 19.2 
4 Vertical 54.70 12.26 8.8 
Horizontal 65.86 8.94 27.10 
5 Vertical 72.74 19.77 16.91 




Table 4 - Plot statistics corresponding to the absolute dose curves in Figures 19-23 
for target films irradiated with constant horizontal motion, compared to the 
reference film with no motion 






6 Vertical 98.12 7.68 29.13 
Horizontal 58.17 9.68 12.23 
7 Vertical 50.39 0.95 13.71 
Horizontal 21.62 7.48 6.95 
8 Vertical 67.69 7.80 18.09 
Horizontal 40.86 9.40 8.57 
9 Vertical 87.42 21.67 20.99 
Horizontal 62.77 24.71 10.81 
10 Vertical 114.53 17.73 36.98 




CHAPTER 5. CONCLUSION  
When considering the movement of an intracranial tumor during treatment on the 
Leksell Gamma Knife Icon system, it is inaccurate to simply state that the movements are 
either less than or equal to the movements at the nose of a patient as observed by the 
motion management system. Instead, the patient geometry, which considers the location 
of the tumor in relation to both the nose and the pivoting point at the C1 vertebra, should 
be accounted for as well.  
With the use of a stereotactic QA phantom, GAFChromic film placed at the center 
of this phantom, and a platform device that produced constant patient-like chin 
movements, it was shown that motion at a tumor could be much greater than what is 
observed by the motion management system. Realistically, a patient would not be able to 
be treated with the GK while moving more than 3 mm, where this deviation was 
observed, and constant patient motion is also not a concern for this treatment. However, 
depending on the location of the tumor, readings of the HDMM may not correlate with a 
smaller movement at the tumor. By primary evaluation, it can be stated that more 
superior tumors can have greater movement during treatment than what is observed and 
predicted by the white paper documentation of the IFMM system. Not only should the 
location of the tumor in the skull be considered but also the location of the tumor in 
relation to the nose and pivot point at the neck of the patient as well. Additionally, when 
discussing tumor coverage for a moving target or a particularly fidgety patient, the 
prescription isodose line may play a key factor in the quality of the treatment delivery.  
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To further evaluate these findings in the future, the platform device could be 
modified to perform more stable movements. These modifications may include an 
upgrade to a metal driving linkage and metal adjustment screws, which would rid the 
setup of any extra motion between oscillations and make the IFMM readings more stable 
between each level of motion. This would also allow the step sizes of the levels of motion 
to be chosen more clearly and observed more accurately. The position of the driving 
linkage connection with the pivoting frame could also be placed in a more stabilizing 
location for each direction. For example, the linkage position for the vertical direction 
could be centered at the top or bottom of the frame to produce a cleaner motion, and the 
position for the horizontal motion could be moved to one of the sides of the frame 
instead. This would cut down any additional torqueing of the pivoting frame that may 
cause discrepancies in the dose delivery. Additionally, to refine the testing and prevent 
the extreme case of continuous motion during irradiation, a motor controller for the 
platform could be programmed to exhibit the actual movements of a patient as read by 
the IFMM during heightened points of movement in an actual treatment.   
The incorporation of the integrated CBCT and IFMM systems has provided a 
more comfortable treatment option for Gamma Knife patients. However, before new 
treatments can be conducted with the Leksell Gamma Knife Icon, all system upgrades 
and modifications should be properly tested for every potential clinical situation. Patients 
count on the therapeutic devices that administer their treatments to provide them the best 
possible outcome as described by their function, which is communicated to the patient by 
the radiation team. However, it is the job of the medical physicist, specifically, to ensure 
that each patient receives the best treatment possible. This includes the production and 
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approval of optimized treatment plans and the assurance that the plans are delivered in 
the most accurate way possible. As technology continues to progress and treatment 
machines become more complex, a continued effort must be made to understand and 
investigate their methodology, as well as to consider the physical additions that 
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